Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04639388 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Understanding of Psychotic Disorders in Children With 22q11.2DS

Study acronym: PremiCeS22
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 30, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Oct 31, 2024 to Jun 30, 2026
    • Study completion date: Jan 31, 2025 to Sep 30, 2026
    v4
  2. 2 versions Re-verified since Jan 26, 2022, no change to tracked fieldsv2-v3
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study PremiCeS22 will investigate the prodromal signals at the onset of psychotic disorders of children with 22q11.2 deletion syndrome
Trial Details
NCT Number NCT04639388
Lead Sponsor Hôpital le Vinatier
Conditions
(from sponsor)		 22q11.2 Deletion Syndrome
Related terms DiGeorge Syndrome
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov